Le Lézard
Classified in: Ebola virus, Health
Subject: ACC

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT 2022


Zinzino group revenue increased with a total of 6% in Q4 and 5% for the full year 2022, compared with the previous year

GOTHENBURG, Sweden, Jan. 4, 2023 /PRNewswire/ -- The revenue in December for Zinzino's sales markets decreased by 16% and amounted to SEK 120.2 (143.8) million. Faun Pharma's external sales decreased by 4% and amounted to SEK 5.0 (5.2) million. Overall, the Group decreased revenues by 16% to SEK 125.2 (149.0) million compared with the previous year.

Sales in Zinzino's sales markets increased by 6% in the fourth quarter of 2022 compared with the same period last year and amounted to SEK 409.7 (386.1) million. Total revenues in the Group increased by 6% in the fourth quarter and amounted to SEK 425.5 (401.2) million.

Accumulated revenue for January ? December 2022 increased by 5% compared with the same period last year and amounted to SEK 1439.3 (1370.6) million.

Revenues were distributed as follows:

Regions, mSEK

22-dec

21-dec

Change

Q4
2022

Q4
2021

Change

YTD
2022

YTD
2021

        Change       
                               

The Nordics

31.0

36.4

-15 %

87.7

98.9

-11 %

323.4

369.8

-13 %

Central Europe

27.6

27.5

0 %

94.1

70.2

34 %

290.6

232.7

25 %

East Europe

27.1

32.2

-16 %

103.5

99.1

4 %

341.3

337.1

1 %

South & West Europe

14.8

16.8

-12 %

50.5

44.2

14 %

164.5

147.1

12 %

The Baltics

7.1

10.4

-32 %

25.2

27.0

-7 %

77.8

79.2

-2 %

North America

5.7

6.1

-7 %

25.2

15.2

66 %

77.2

51.3

50 %

Asia-Pacific

5.6

13.9

-60 %

19.6

30.4

-36 %

77.3

89.7

-14 %

Africa

1.3

0.5

160 %

3.9

1.1

255 %

10.1

1.1

818 %

Zinzino

120.2

143.8

-16 %

409.7

386.1

6 %

1362.2

1308.0

4 %

Faun Pharma

5.0

5.2

-4 %

15.8

15.1

5 %

77.1

62.6

23 %

Zinzino Group

125.2

149.0

-16 %

425.5

401.2

6 %

1439.3

1370.6

5 %

 

Countries in regions:

For more information:

Dag Bergheim Pettersen
CEO Zinzino
+47 (0) 932 25 700,
zinzino.com

Pictures for publication free of charge: 
[email protected]

Certified Adviser: 

Erik Penser Bank Aktiebolag,
+46 (0) 8 463 83 00,
Email: [email protected]

Zinzino AB (publ) is obliged to publish this information in compliance with current EU regulations governing market abuse. The information was provided by the above contact person for publication at 11:00 the 4th of January 2023.

The following files are available for download:

https://mb.cision.com/Main/10976/3693147/1763641.pdf

2212 Pressrelease Salesreport EN


These press releases may also interest you

at 07:05
908 Devices Inc. , a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today announced it will participate in the following investor conferences. 2024 Leerink Partners Healthcare Crossroads Conference,...

at 07:05
Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a company overview at the Leerink Partners Healthcare Crossroads Conference...

at 07:05
Blackstone today announced the launch of the Blackstone Life Sciences ("Blackstone") portfolio company Uniquity Bio, a clinical-stage drug development company focused on immunology and inflammation. Uniquity Bio is emerging from stealth with an FDA...

at 07:05
Rondo Therapeutics, a biopharmaceutical company pioneering next-generation bispecific antibodies, announces oral presentations at both Protein & Antibody Engineering Summit (PEGS) and Antibody Engineering & Therapeutics (AET) EU. Rondo Therapeutics...

at 07:05
Oncoinvent AS, a clinical stage company advancing alpha emitter therapy across a variety of solid cancers, today announced that members of management will participate in a virtual fireside chat at the Cantor Fitzgerald Frontiers in Radiopharma...

at 07:05
Harrow , a leading North American eyecare pharmaceutical company, today announced that management will participate in the following two investor conferences in May: B. Riley Securities 24th Annual Institutional Investor Conference (Beverly Hilton...



News published on and distributed by: